Event Brief
Feb 4, 2026 at 9:07 PM ET
Celltrion's Q4 Net More Than Doubles on Biosimilars
By The BriefBrief
Celltrion Inc. reports a significant increase in Q4 net profit due to its expanded biosimilar lineup.
WHO: Celltrion Inc.
WHAT: Q4 net profit more than doubles
WHEN: Feb 4, 2026 at 7:57 PM ET
WHERE: Seoul, South Korea
WHY: Expansion of biosimilar product lineup
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21432 of 21432
Same format. Every time.
Continue reading — sign in or create a free account with
